BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 29054887)

  • 1. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
    Ying C; Zhang L; Jin X; Zhu D; Wu W
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116254. PubMed ID: 38492490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
    Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
    Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
    Philley JV; Griffith DE
    Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.
    van Ingen J
    Clin Chest Med; 2015 Mar; 36(1):43-54. PubMed ID: 25676518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report.
    Kuge T; Fukushima K; Matsumoto Y; Abe Y; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Kawasaki T; Matsuki T; Kagawa H; Motooka D; Tsujino K; Miki M; Miki K; Kitada S; Nakamura S; Iida T; Kida H
    BMC Infect Dis; 2020 Nov; 20(1):888. PubMed ID: 33238934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nontuberculous mycobacterial pulmonary disease].
    Ringshausen FC; Rademacher J
    Internist (Berl); 2016 Feb; 57(2):142-52. PubMed ID: 26810111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of nontuberculous mycobacterial pulmonary disease.
    Adelman MH; Addrizzo-Harris DJ
    Curr Opin Pulm Med; 2018 May; 24(3):212-219. PubMed ID: 29470253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.
    Larsson LO; Polverino E; Hoefsloot W; Codecasa LR; Diel R; Jenkins SG; Loebinger MR
    Expert Rev Respir Med; 2017 Dec; 11(12):977-989. PubMed ID: 28967797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Banks J; Capstick T; Fisher AJ; Gorsuch T; Laurenson IF; Leitch A; Loebinger MR; Milburn HJ; Nightingale M; Ormerod P; Shingadia D; Smith D; Whitehead N; Wilson R; Floto RA
    Thorax; 2017 Nov; 72(Suppl 2):ii1-ii64. PubMed ID: 29054853
    [No Abstract]   [Full Text] [Related]  

  • 15. Infections caused by opportunist mycobacteria: a review.
    Grange JM; Yates MD
    J R Soc Med; 1986 Apr; 79(4):226-9. PubMed ID: 3517327
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of pulmonary disease caused by non-tuberculous mycobacteria.
    van Ingen J
    Lancet Respir Med; 2015 Mar; 3(3):179-80. PubMed ID: 25773208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
    Huet D; Godbert B; Hermann J; Zordan JM; Chabot F; Andréjak C
    Rev Mal Respir; 2017 Mar; 34(3):257-261. PubMed ID: 27639948
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Braganza Menezes DA; Dedicoat MJ; Robertson A
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29420243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease.
    Moon SM; Jhun BW; Daley CL; Koh WJ
    Eur Respir J; 2019 May; 53(5):. PubMed ID: 30819812
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.
    Henkle E; Aksamit T; Barker A; Daley CL; Griffith D; Leitman P; Leitman A; Malanga E; Marras TK; Olivier KN; Prevots DR; Prieto D; Quittner AL; Skach W; Walsh JW; Winthrop KL;
    Ann Am Thorac Soc; 2016 Sep; 13(9):S379-84. PubMed ID: 27627485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.